[Source: BUSINESS WIRE] – The Arizona BioIndustry Association (AZBio) has added three new members to its Board of Directors, which was restructured earlier this year to assist AZBio in more effectively operating as a unified association representing the interests of all bioscience companies throughout the state.
The three new Directors are Monique Heiser, Vice President and General Manager of the Covance Laboratories facility under construction in Chandler; Randal Schulhauser, Sr., Manager of Technology & Business Development at Medtronic Microelectronic Center in Tempe; and Raymond Woosley, President and CEO of Critical Path Institute in Tucson.
“I’m pleased to welcome these three outstanding individuals to the AZBio Board,” said Michael Mobley, Associate Director of the Biodesign Institute at Arizona State University and Chair of the AZBio Board of Directors. “Arizona’s bioscience companies are part of a global industry, and it will be valuable to have the perspective of these prominent organizations as we continue to develop a varied portfolio of benefits for our members.”
Robert Eaton, AZBio’s President & CEO, said, “AZBio represents all bioscience companies in the state, regardless of geography, size or stage of development. I am excited that our Board of Directors will now more fully represent the spectrum of organizations that make up Arizona’s bioscience community.”
The Arizona BioIndustry Association is a not-for-profit trade association that seeks to unify, empower and advance its member organizations, who collectively form Arizona’s bioscience community, and to make Arizona a place where bioscience companies can grow and succeed. AZBio is the state affiliate in Arizona for both the Biotechnology Industry Organization (BIO), the preeminent trade association for the biotechnology industry in the United States, and AdvaMed, a national trade association whose members produce nearly 90 percent of the health care technology purchased annually in the United States.
Covance, with headquarters in Princeton, New Jersey, is one of the world’s largest and most comprehensive drug development services companies with annual revenues greater than $1.5 billion, global operations in more than 20 countries, and more than 8,900 employees worldwide. Information on Covance’s products and services, recent press releases, and SEC filings can be obtained through its website at www.covance.com.
Medtronic, Inc., headquartered in Minneapolis, is the world’s leading medical technology company, alleviating pain, restoring health and extending life for people with chronic disease. Each year, over 6 million patients benefit from Medtronic’s technologies used to treat conditions such as heart disease, spinal conditions, neurological disorders, vascular disease and diabetes. Medtronic has almost 38,000 employees working in over 120 countries, generating annual revenues exceeding $13.505B. ( www.medtronic.com)
Critical Path Institute, headquartered in Tucson, Arizona, with offices in Rockville, Maryland, was established in 2005 as a publicly funded, nonprofit research and education institute to enable collaborations between scientists from the FDA, industry and academia. Critical Path Institute’s mission is to help implement the FDA’s Critical Path Initiative by developing faster, safer and smarter pathways to new medical products. Visit www.C-Path.org for more information.
SOURCE: The Arizona BioIndustry Association Arizona BioIndustry Association
Robert Eaton, 602-495-2937